- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.10. | Sona Nanotech Inc: Sona Nanotech sees 80% response in cancer study | 1 | Stockwatch | ||
| 20.10. | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 502 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 18.10. | Sona Nanotech Inc: Sona Nanotech to host investor webinar Oct. 20 | 1 | Stockwatch | ||
| 17.10. | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 914 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen | |
| 26.08. | Sona Nanotech Inc: Sona completes treatment of first patient cohort in FS | 3 | Stockwatch | ||
| 25.08. | Sona Nanotech advances cancer therapy with promising early results | 1 | The Market Herald Canada | ||
| 25.08. | Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial | 756 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 23.07. | Sona Nanotech Inc: Sona receives ethics board OK for THT pilot human study | 1 | Stockwatch | ||
| 23.07. | Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval | 671 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 08.07. | Sona Nanotech doses first patient in groundbreaking cancer therapy trial | 1 | The Market Herald Canada | ||
| 08.07. | Sona Nanotech Inc: Sona completes first dosing in early FS trial | 1 | Stockwatch | ||
| 07.07. | Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy | 876 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 27.06. | Sona Nanotech Inc: Sona receives committee approval for melanoma trial | 2 | Stockwatch | ||
| 27.06. | Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial | 640 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies... ► Artikel lesen | |
| 17.06. | Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia | 7 | Stockwatch | ||
| 16.06. | Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy | 559 | Newsfile | First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life... ► Artikel lesen | |
| 27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 815 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
| 15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 1.092 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
| 07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 853 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
| 07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 935 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,800 | +0,63 % | Puma Aktie: Rallychancen?, DAX-Indizes, Evotec, Formycon und Laiqon im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| ONTO INNOVATION | 132,00 | -3,65 % | Onto Innovation Inc. (ONTO): A Bull Case Theory | ||
| GAUZY | 1,200 | 0,00 % | Gauzy Ltd. Raises $12 Million Investment to Advance Capital Objectives and Provides Update on Board Composition | TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has raised... ► Artikel lesen | |
| VEECO INSTRUMENTS | 27,400 | -0,72 % | Veeco Instruments Inc.: Veeco Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Highlights: Revenue of $165.9 million, compared with $184.8 million in the same period last yearGAAP net income of $10.6 million, or $0.17 per diluted share, compared with $22.0... ► Artikel lesen | |
| KOPIN | 2,216 | -7,90 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| SOLESENCE | 2,060 | -5,94 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,272 | -17,58 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| DOTZ NANO | 0,029 | -5,00 % | DOTZ NANO LIMITED: Dotz Small Cap Investor Conference Highlights & Presentation | ||
| INSPLORION | 0,000 | +100,00 % | Insplorion AB: Quarterly report Q3 2025 | July - September
Outcome July - SeptemberNet sales amounted to 926 (490) kSEKProfit after financial items amounted to -3,133 (-3,459) kSEKEarnings per share before and after dilution: SEK -0,04 (-0... ► Artikel lesen | |
| ACACIA RESEARCH | 3,140 | 0,00 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| ADVANCE ZINCTEK | 0,620 | 0,00 % | ADVANCE ZINCTEK LIMITED: Response to Television Broadcast Early This Week | ||
| LAMPETIA | 0,068 | +3,03 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 1,810 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| RIBER | 3,315 | 0,00 % | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen | |
| NANOVIRICIDES | 1,030 | -0,96 % | NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles | SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen |
SONA NANOTECH INC gehört der Branche Nanotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.